Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
City of Hope Medical Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
First Affiliated Hospital of Zhejiang University
University of Nebraska
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Virginia Commonwealth University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Sun Yat-sen University
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
University of Washington
National Cancer Institute (NCI)
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
Children's Oncology Group
M.D. Anderson Cancer Center